<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

The Cancer Letter

Introducing a redesign of The Cancer Letter

Free

Introducing a redesign of The Cancer Letter

January 06, 2017

MD Anderson lays off 900 staff members

Free

MD Anderson lays off 900 staff members

January 06, 2017

By Paul Goldberg

Doug Lowy on the moonshot, NCI’s invigorated agenda

Free

Doug Lowy on the moonshot, NCI’s invigorated agenda

January 06, 2017

Biden plans to create moonshot nonprofit, may focus on drug prices

Free

Biden plans to create moonshot nonprofit, may focus on drug prices

December 22, 2016

By Matthew Bin Han Ong

Lilly Presents Phase II Data on Abemaciclib in Early Breast Cancer

December 22, 2016

NCI CTEP-Approved Trials for December

December 22, 2016

Opioids Not Helpful in Treating Chronic Pain, Geisinger Study Finds

December 22, 2016

Immune Response to HPV Has Impact on Prognosis

December 22, 2016

Cellular Immunotherapy Targets a Common Human Cancer Mutation

December 22, 2016

Drugs & Targets

FDA Approves Indications for Rubraca and Avastin

December 22, 2016